KDM4A and non-small cell lung carcinoma: The tri-methyl selective KDM4A/JMJD2A demethylase is an AR coregulator [72] expressed in PCa [14] and is a determinant of mTOR inhibitor sensitivity in non-small cell lung cancer patients [81].